AMRI, which is modified CAS covered, has the infrastructure and requisite accounting practices to support government contracting, including budget tracking, invoicing and level-of-effort reporting.

AMRI’s IT systems are Section 508 compliant and appropriate processes and training are in place for data transfer, IT security and compound management. AMRI also practices strict confidentiality, as we understand the importance of protecting our customers’ intellectual property.

With decades of experience delivering expert solutions to pharma, biotech, academic and government organizations, AMRI has mastered the art of scientific innovation. As your trusted partner, we provide the high-value services you need across the entire continuum — from drug discovery and small-scale development to API and drug product commercial manufacturing. We offer a competitive track record of program and product advancement, as well as a documented history of inspection success.

Company Designations:
Cage Code: 3D1R9
Duns #: 787793900
SAM Registration: Active
SAM Expiration Date: 9/1/2021

NAICS Codes:
325411 – Medicinal and Botanical Manufacturing
325412 – Pharmaceutical Preparation Manufacturing
325413 – In-Vitro Diagnostic Substance Manufacturing
541380 – Testing Laboratories
541690 – Other Scientific and Technical Consulting Services
541714 – Research and Development in Biotechnology (except Nanobiotechnology)
541715 – Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Certifications and Compliance:
FDA Approved
SafeBridge® Potent Compound Safety Certified
MHRA (UK) Certified
AIFA (Italy) Certified
Section 508 compliant